Omeprazole efficacy in treating gastritis
Pro Research Analysisby 
Searched over 200M research papers
Omeprazole Efficacy in Treating Acute Gastritis
Several studies have evaluated the effectiveness of omeprazole, both alone and in combination with other medications, for treating acute gastritis. When combined with atropine, omeprazole has shown a higher total effective rate, faster symptom relief (such as stomach pain, abdominal distension, and nausea), and a lower incidence of adverse reactions compared to combinations with other antispasmodics like anisodamine. This combination also led to significant reductions in inflammatory markers and improvements in gastrointestinal hormone levels, supporting its clinical use for acute gastritis management Liang2025Lin2021Sunarti2019.
Omeprazole in Chronic Gastritis: Clinical Outcomes
For chronic gastritis, omeprazole alone or in combination with other agents has demonstrated notable efficacy. Studies show that omeprazole, when combined with famotidine or clarithromycin, results in higher overall treatment effectiveness and fewer adverse reactions compared to monotherapy. These combinations also help improve patients’ quality of life by reducing symptoms and promoting regularity in daily activities Qunfen2014Yue-A2014.
Omeprazole and Traditional Medicine Combinations
Research has also explored the use of omeprazole with traditional medicine formulas, such as Yiqi Yangyin and matrine. These combinations have been found to further improve clinical symptoms, reduce the incidence of upper abdominal discomfort, and lower levels of inflammatory markers. Additionally, they may enhance the eradication rate of Helicobacter pylori and improve histopathological outcomes in chronic atrophic gastritis Logan1995Gottrand2001.
Cost-Effectiveness and Comparative Efficacy
Omeprazole has been shown to be more cost-effective than ranitidine for gastritis treatment, with a higher percentage of patient recovery and lower cost per unit of effectiveness. This makes omeprazole a preferred choice in terms of both clinical and economic outcomes .
Omeprazole’s Impact on Gastric Mucosa and Helicobacter pylori
Long-term use of omeprazole is generally safe and effective for acid suppression, with a low incidence of adverse changes in the gastric mucosa, especially in patients without pre-existing severe gastritis. Omeprazole also affects the distribution of Helicobacter pylori in the stomach, reducing its presence in the antrum and shifting colonization to the fundus, which is associated with changes in gastritis activity Klinkenberg‐Knol2000Xue2025.
Conclusion
Omeprazole is effective and safe for treating both acute and chronic gastritis, especially when used in combination with other medications or traditional therapies. It provides rapid symptom relief, improves clinical outcomes, and is cost-effective compared to alternatives. Its use is supported by reductions in inflammation, improvements in gastric function, and favorable safety profiles across various patient groups.
Sources and full results
Most relevant research papers on this topic
Atropine plus omeprazole for acute gastritis: Efficacy and safety analysis.
Atropine plus omeprazole is a significant and safe treatment for acute gastritis, with shorter symptom remission times and reduced adverse reactions.
The clinical efficacy and safety of atropine combined with omeprazole in the treatment of patients with acute gastritis: a systematic review and meta-analysis.
Combined atropine and omeprazole effectively treat acute gastritis with few adverse reactions and effectively alleviates clinical symptoms.
Long-term omeprazole treatment in resistant gastroesophageal reflux disease: efficacy, safety, and influence on gastric mucosa.
Long-term omeprazole therapy (up to 11 years) is highly effective and safe for controlling reflux esophagitis in patients not eligible for surgery.
Observation of the curative efficacy of Yiqi Yangyin formula in combination with omeprazole in the treatment of patients with chronic atrophic gastritis
Yiqi Yangyin formula combined with omeprazole effectively treats chronic atrophic gastritis, significantly improving clinical symptoms and reducing serum epidermal growth factor levels.
DOI